Your browser doesn't support javascript.
loading
Targeted genome fragmentation with CRISPR/Cas9 enables fast and efficient enrichment of small genomic regions and ultra-accurate sequencing with low DNA input (CRISPR-DS).
Nachmanson, Daniela; Lian, Shenyi; Schmidt, Elizabeth K; Hipp, Michael J; Baker, Kathryn T; Zhang, Yuezheng; Tretiakova, Maria; Loubet-Senear, Kaitlyn; Kohrn, Brendan F; Salk, Jesse J; Kennedy, Scott R; Risques, Rosa Ana.
Afiliação
  • Nachmanson D; Department of Pathology, University of Washington, Seattle, Washington 98195, USA.
  • Lian S; Department of Pathology, University of Washington, Seattle, Washington 98195, USA.
  • Schmidt EK; Department of Pathology, University of Washington, Seattle, Washington 98195, USA.
  • Hipp MJ; Department of Pathology, University of Washington, Seattle, Washington 98195, USA.
  • Baker KT; Department of Pathology, University of Washington, Seattle, Washington 98195, USA.
  • Zhang Y; Department of Pathology, University of Washington, Seattle, Washington 98195, USA.
  • Tretiakova M; Department of Pathology, University of Washington, Seattle, Washington 98195, USA.
  • Loubet-Senear K; Department of Pathology, University of Washington, Seattle, Washington 98195, USA.
  • Kohrn BF; Department of Pathology, University of Washington, Seattle, Washington 98195, USA.
  • Salk JJ; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, Washington 98195, USA.
  • Kennedy SR; Department of Pathology, University of Washington, Seattle, Washington 98195, USA.
  • Risques RA; Department of Pathology, University of Washington, Seattle, Washington 98195, USA.
Genome Res ; 28(10): 1589-1599, 2018 10.
Article em En | MEDLINE | ID: mdl-30232196

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Proteína Supressora de Tumor p53 / Análise de Sequência de DNA / Sistemas CRISPR-Cas Limite: Female / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Proteína Supressora de Tumor p53 / Análise de Sequência de DNA / Sistemas CRISPR-Cas Limite: Female / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article